Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Biology and management.
Kaposi's Sarcoma (KS), the most common AIDS-associated malignancy, occurs with increased frequency in all HIV transmission groups, but at a particularly high rate in homosexual men. Recent studies suggest that KS pathogenesis involves exposure to an infectious agent, altered expression and response to cytokines, and modulation of growth by HIV gene products. KS varies in its clinical presentation from a relatively indolent process to a widely disseminated, aggressive disease. A variety of local and systemic treatments provide effective, but usually temporary, disease palliation. Insights into KS pathogenesis suggest a number of targeted therapeutic approaches that may eventually lead to improved disease management and disease cure.
Krown
S E
SE
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D003131:Combined Modality Therapy; D006801:Humans; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy